Announced details
Multiple industry sectors, including papermaking
Economic ripple effect of investment: ¥66.7 trillion through FY2040
Supports the development, mass production, and commercial deployment of bio-based products by operating companies, including paper manufacturers.
No specific earnings impact has been provided. The Company aims to increase corporate value over the medium to long term.
The company does not address Contract Value / Offering price.
5th Japan Growth Strategy Council meeting; Cabinet Secretariat, "Draft Public-Private Investment Roadmap for Major Products and Technologies in 17 Strategic Areas"
| Item | Details |
|---|---|
| Names of Products / Services Covered | Bio-manufacturing, technology platforms, and process development |
| Relationship with the Company | Supports the development, mass production, and commercial deployment of bio-based products by operating companies, including paper manufacturers. |
| Applicable area | Multiple industry sectors, including papermaking |
| Quantitative Effects | Economic ripple effect of investment: ¥66.7 trillion through FY2040 |
| Impact on Business Performance | No specific earnings impact has been provided. The Company aims to increase corporate value over the medium to long term. |
| Source | 5th Japan Growth Strategy Council meeting; Cabinet Secretariat, "Draft Public-Private Investment Roadmap for Major Products and Technologies in 17 Strategic Areas" |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Bio-manufacturing was identified as a priority area in the government's growth strategy at the Japan Growth Strategy Council, and increases are expected in capital investment, research and development investment, and commercialization projects.